JosephWeissMDPh.D.
Cardiology • Newport, RIAdult Congenital Heart Disease, Cardiovascular Disease Genetics
Lifespan CVI, Newport Hospital
Dr. Weiss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
19 Friendship St
Suite 260
Newport, RI 02840Phone+1 401-845-1201Fax+1 401-845-1291
Summary
- Dr. Joseph Weiss is a Cardiology specialist based in Newport, RI with a focus on adult congenital heart disease and cardiovascular disease genetics. He completed his education in 1988 at New York University School of Medicine, and a residency in internal medicine at New York Presbyterian Hospital from 1988 - 1991. Currently, he is an attending physician at Lifespan CVI, and his medical expertise extends to hypertrophic cardiomyopathy and congenital heart diseases among others. He has published multiple papers targeting the role of anaplastic lymphoma kinase in brain function with special consideration for Neurofibromatosis Type 1 (Nf1). Dr. Weiss has been recognized with the CMS Meaningful Use Stage 1 Certification by Epic Systems Corporation in 2011-2012.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1988 - 1991
New York University School of MedicineClass of 1988
Certifications & Licensure
OR State Medical License 2002 - Present
RI State Medical License 2014 - 2026
WA State Medical License 2013 - 2016- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Publications & Presentations
PubMed
- 1 citationsInhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1).Joseph B Weiss, Jacob Raber
Cancers. 2023-09-15 - Long-term effects of pharmacological inhibition of anaplastic lymphoma kinase in neurofibromatosis 1 mutant mice.Destine Krenik, Joseph B Weiss, Jacob Raber
Behavioural Brain Research. 2022-04-09 - 2 citationsRole of the parental NF1 carrier in effects of pharmacological inhibition of anaplastic lymphoma kinase in Neurofibromatosis 1 mutant mice.Destine Krenik, Joseph B. Weiss, Jacob Raber
Brain Research. 2021-10-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
